Mesothelioma Information

iMesothelioma.info

Latest Mesothelioma News

Latest Mesothelioma Articles

About Mesothelioma
What is the mesothelium?
What is mesothelioma?
How common is mesothelioma?
What are the risk factors for mesothelioma?
Who is at increased risk of developing mesothelioma?
What are the symptoms of mesothelioma?
How is mesothelioma diagnosed?
How is mesothelioma treated?
Are new treatments for mesothelioma being studied?

Mesothelioma and Asbestos

Malignant Mesothelioma and Treatment
Stages of Malignant Mesothelioma
Recurrent Malignant Mesothelioma
Treatment option overview
Treatment options for Malignant Mesothelioma

Clinical Trials

Statistics

Latest Mesothelioma News

Dennis Metzer
Dennis Metzer, 70, of Nashwauk, returned his soul to the Lord on Saturday, July 24, 2010, in his home after a 10-month journey with mesothelioma. He was born Jan. 16, 1940, in Hibbing, the son of Charles and Marie Metzer.

LawyersandSettlements.com Launches Asbestos Hot Spot News Map to Track Litigation Updates
Map Summarizes U.S. Asbestos and Mesothelioma Legal News Coverage

Rosetta Licenses Greek miRNA Dx Rights to Genekor
Rosetta Genomics said this week that it has signed a deal making Genekor the exclusive distributor of its three microRNA-based diagnostics in Greece.

Genekor to Distribute Rosetta Genomics' Assays
NEW YORK (GenomeWeb News) Rosetta Genomics today said that it has granted exclusive distribution rights in Greece for three of its assays to Genekor, an Athens-based molecular diagnostics firm.

Press Release
Rosetta Genomics Ltd. Posted on:29 Jul 10 Rosetta Genomics, Ltd. (NASDQ:ROSG), a leading developer of microRNA-based molecular diagnostics, and Genekor S.A, a leading molecular diagnostic service provider in Greece, announced today the signing of an exclusive distribution agreement for three of Rosetta Genomics